-
Although chronic oral antiarrhythmic prophylaxis and catheter ablation both enjoy great success for preventing recurrences of atrial fibrillation (AF), some patients are not appropriate candidates for either method, especially patients with infrequent recurrences of AF.
-
Statins lower the levels of c-reactive protein (CRP) as well as the levels of LDL cholesterol (LDL-C). Whether lowering the CRP affects the clinical outcomes of statin therapy has not previously been investigated.
-
The addition of antiplatelet therapy to reduced intensity anticoagulation in atrial fibrillation patients reduces death and embolic events without increasing bleeding.
-
Pravastatin is the statin with the least interactions with cytochrome P450-(CYP) 3A4 inhibitors.
-
A new nonbenzodiazepine hypnotic has been approved by the FDA for the treatment of insomnia.
-
The most commonly prescribed statins have a low incidence of rhabdomyolysis, according to the results a new study of more than 250,000 patients.
-
Sasser H. Antioxidant use during chemo- and radiotherapy for cancer. Altern Med Alert 2005;8(2):13-17.
-
Keegan L. Complementary and alternative therapies and end-of-life care: Part 1. Altern Med Alert 2005;8(2):17-20.
-
Kiefer D. Cat's claw: Traditional and clinical uses. Altern Med Alert 2005;8(2):20-24.
-
Greenfied RH. Ayurvedic products and heavy metals. Altern Med Alert 2005;8(2):24.
